|
Notice to our subscribers currently receiving printed copies of our magazine: Due to COVID-19, we are delivering each issue to you via email. Please note your issues will also still be delivered to you via postal mail, and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.
|
| |
|
|
|
|
|
|
TOP STORIES
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
|
|
Second Genome will use its Microbiome Analytics Platform throughout the collaboration to identify novel biomarkers associated with clinical response to Gilead’s investigational medicines
/ read more /
|
|
| |
ADVERTISEMENT
Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
| |
advertisement
|
|
Industry News
The drug discovery platform was developed to rapidly predict blocking of COVID-19 pneumocyte cellular entry.
/ read more /
Belgian biopharmaceutical company, UCB, has successfully completed its acquisition of Ra Pharmaceuticals, which is now a wholly-owned subsidiary of the company.
/ read more /
MORE INDUSTRY NEWS
|
advertisement
|
| |
|
Biopharma News
The company is advancing its lung-selective nebulized Janus kinase inhibitor into clinical development to determine its ability to prevent acute lung injury in patients with COVID-19.
/ read more /
Horizon Discovery has announced that it has expanded its cell-based clustered regularly interspaced short palindromic repeats (CRISPR) screening services to include primary human B cells, which complements the T cell screening service.
/ read more /
More Biopharma News
|
|
| |
|
Supplier News
Suppliers to the bio/pharma industry are sharing news about the business operations during the global COVID-19 pandemic. To view current information about the company’s business operations, click the company name.
/ read more /
|
|
The partners have formed a joint venture to produce muscle-derived mesenchymal stem cells as a source of exosomes and other cellular products to develop related therapies and advance clinical trials.
/ read more /
More Supplier News
|
|
Regulatory News
The agency has been tasked with coordinating efforts to mitigate shortages of medicines within Europe during the COVID-19 pandemic.
/ read more /
|
EMA's CHMP has recommended the use of remdesivir, an investigational antiviral medicine, in compassionate use programs across the European Union.
/ read more /
More Regulatory News
|
|
|
|
|
|
ANALYTICAL METHODS
A variety of assays should be used to detect bacterial, fungal, and viral contaminants in the human source cells used for cell therapies.
/ read more /
|
|
|
|
|
MANUFACTURING
Single-use solutions continue to grow in popularity, largely as a result of the cost and time efficiencies they can afford biopharma companies.
/ read more /
|
|
|
|
UPSTREAM PROCESSING
New bioreactor designs, coupled with better media, process intensification and analytics, continue to improve upstream bioprocessing.
/ read more /
|
|
|
WEBCASTS
Simple and Effective Methods for Purification and Determination of Molecular Weight of DMT-on and DMT-off Oligonucleotides
Wednesday, April 22, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More
Implementing Attribute Monitoring Analyses for Biopharmaceutical Development and QC
Wednesday, April 29, 2020, 9am EDT| 2pm BST| 3pm CEST
Learn More
Practical Method Development Strategies for the Analysis of Monoclonal Antibodies by Reversed-Phase HPLC
Thursday, May 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More
An In-Depth Look at Intact Biotherapeutic Characterization and Quantitation in Biological Matrices
Europe Broadcast: Thursday, April 23, 2020 at 9am EDT | 2pm BST | 3pm CEST
US Broadcast: Thursday, April 23, 2020 at 2pm EDT | 1pm CDT | 11am PDT
Learn More
|
Rescheduled Events
CPhI South East Asia has been rescheduled for July 2020.
Interphex 2020 has been rescheduled for July 2020.
PDA’s Annual Meeting has been rescheduled for July 2020.
Bioprocessing Summit Europe has been rescheduled for July 2020.
PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.
CPhI North America has been rescheduled for September 2020.
CPhI Japan has been rescheduled for September 2020.
Analytica 2020 has been rescheduled for October 2020.
Interpack 2020 has been rescheduled for February 2021.
more events
|
|
|
eBook
|
In BioPharm International’s Pharmacopoeia Compliance Series, experts explain the revision process for global and national pharmacopoeias, best practices for monitoring changes, and how to participate in revisions. Other features include FDA warning letters, FDA Form 483s, and essentials for quality risk management.
|
|
|
|
| |
